| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.24 | 8e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.23 | 8e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.2 | 0.0009 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |